IMPORTANT MENTION: An RCT came out earlier this week in @JAMAInternalMed by my former @MedChiefs co-resident @BenjaminAbella and colleagues Key finding: #hydroxychloroquine does not prevent #COVID19 ps-negative studies do need attention https://t.
Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers: https://t.co/OECGQE46Zb
RT @OutOfTheDarkAge: 600mg a day of #Hydroxychloroquine for 56 days for prophylaxis. Irrespective of body weight. https://t.co/ts4mEhwOdE
RT @EricFMorand: No effect of Hydroxychloroquine for Pre-exposure SARS-CoV-2 Prophylaxis Among HCW https://t.co/5fieiuUCaW via @JAMAInterna…
RT @CollignonPeter: 132 participants (median age, 33 years [range, 20-66 years]. There was no significant difference in infection rates in…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/KmCaTMvHjd via @JAMAInternalMed part of @JAMANetwork
RT @DieTukkerfries: Ja maar zink. https://t.co/rMGubsKLaw
RT @DieTukkerfries: Ja maar zink. https://t.co/rMGubsKLaw
Ja maar zink. https://t.co/rMGubsKLaw
Daily hydroxychloroquine fails as pre-exposure prophylaxis for SARS-CoV-2 infection https://t.co/sqeSGLbN0V Shared from Epocrates, The #1 medical reference app. https://t.co/6B3jbzYYWk https://t.co/Na9uMHK6gR
TL;DR it def doesn’t work https://t.co/5ZJDbzMRrX
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
The publication 2 days ago of this RCT of HCQ vs. placebo for prophylaxis of COVID19 in HCWs—which was stopped early for futility—is timely to say the least: https://t.co/sj9LUOQUV4
RT @drpatrickholmes: Daily hydroxychloroquine (HCQ) did not prevent SARS-CoV-2 infection (#COVID19 ) in health care workers in this small…
RT @sminaev2015: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A…
Another RCT proving HCQ does not work https://t.co/GlTlOYIaLd
Oh, dear, yet another nail in the coffin of HCQ for Covid-19. https://t.co/APay09uc3o
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
Trump’s touted “Miracle Cure” to COVID-19; There was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19. In English; Shit don’t work, wear a mask.
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
@ScottAdamsSays This was doing the rounds. "Among hospital-based health care workers, daily HCQ did not prevent SARS-CoV-2 infection, although the trial was terminated early and may have been underpowered to detect a clinically important difference." https
@SOwl57 Recent study: https://t.co/L72j6vc7ld
RT @joseramosvivas: Ensayo clínico pre-exposición en #sanitarios: La hidroxicloroquina no protege del #coronavirus ni aunque te construyas…
RT @tipssovetorax: Evidencia que la Hidroxicloroquina NO previene infección por SARS CoV2.
@alketamark @realDonaldTrump @FLOTUS Oops. Bad advice. https://t.co/t8e8VjjGv4
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/lqAmln5hVW via @JAMAInternalMed part of @JAMANetwork
There was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19. https://t.co/fHkaf6WPgF Looks like we have some research to go with our Presidential
@jason_tate Perfect timing because a study just came out about it not having any effect https://t.co/4KzGYpx33D
@rabois I eagerly await your reaction to this peer reviewed randomized trial in JAMA: https://t.co/iItNJZ297u
@Qriticalpath @Jason @dollymad1812 Hydroxychloroquine was useless in preventing #COVID19 https://t.co/DhS5Y2BFGK
"Conclusions This randomized clinical trial did not detect a reduction in SARS-CoV-2 transmission with prophylactic administration of hydroxychloroquine" https://t.co/9RX8U9k8zN
RT @drilkerbelek: JAMA Dergisinde 30 Eylül'de yayımlanan bir hidroksiklorokinin hastane çalışanlarını Covid-19'dan korumadığını gösteriyor.…
@tkhaskin @TheRightMelissa No clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19: https://t.co/PJwdnny16d
"In this RCT, although limited by early termination, there was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19." @JAMAInternalMed @JAMA_current h
@LorrieNJ50 @Hagstrom_Anders @DailyCaller @FLOTUS “...there was not a significant difference in reverse-transcriptase polymerase chain reaction–confirmed SARS-CoV-2 incidence between hydroxychloroquine and placebo cohorts.” https://t.co/rIRALDstoX
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network @lookner https://t.co/s1PDXC6nu1
Apoco la hidroxicloroquina no funciona como preventivo del COVID ??? Aaaaa pero háganle caso a la comadre o a la tía pero no a los científicos... https://t.co/II2wvE5MCQ
Fresh off the press! https://t.co/H6KjKO0jJ4
RT @derickwaderehab: Trump is not always factually correct. Hydroxychloroquine does not have a detectable benefit in preventing development…
#Hydroxychloroquine No More Effective Than Placebo in Preventing #COVID19 https://t.co/VgDlIVFAMF & https://t.co/tp54XTzX98
@FrancoisLevel1 @brossarda1 @RenaudMuselier @medicalfollower @raoult_didier Ca ne marche pas non plus a Garches. C’est juste de la communication.
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network Uh oh Trumpy! https://t.co/7hi1yh3Pib
RT @EricFMorand: No effect of Hydroxychloroquine for Pre-exposure SARS-CoV-2 Prophylaxis Among HCW https://t.co/5fieiuUCaW via @JAMAInterna…
RT @OJBoyau: Et encore une étude. Donc HCQ ça fonctionne pas en prophylaxie, en précoce, en tardif, associé ou non à AZT. Et avec plus d'ef…
#هیدروکسی_کلرکین در محافظت کادر درمان در برابر #کرونا نقشی نداشته. #COVID19
RT @joseramosvivas: Ensayo clínico pre-exposición en #sanitarios: La hidroxicloroquina no protege del #coronavirus ni aunque te construyas…
RT @Lester_Domes: JAMA again supplies an example of weasel wording for noninformative data & why we need to drop traditional stat descripti…
No effect of Hydroxychloroquine for Pre-exposure SARS-CoV-2 Prophylaxis Among HCW https://t.co/5fieiuUCaW via @JAMAInternalMed part of @JAMANetwork
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
https://t.co/L1vlffZUeN There was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19. #sciencenews https://t.co/yec4UyU4HZ
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial | Infectious Diseases | JAMA Internal Medicine | JAMA Network https://t.co/1GVwgY72Oq
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
“there was not a significant difference in reverse-transcriptase polymerase chain reaction–confirmed SARS-CoV-2 incidence between hydroxychloroquine and placebo cohorts.” It was never a conspiracy. HCQ just didn’t work, as this once again proves. https://
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
This is Fake Science and Fake News! https://t.co/DihAPq0jQ1
RT @aussiecoley: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://…
Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.co/WnDeKm4MRC via @JAMAInternalMed part of @JAMANetwork
RT @CrestaniFilho: Poucas coisas são tão certas na medicina quanto a ausência de benefícios da Cloroquina na COVID-19, já é nível de evidên…
There was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in h https://t.co/1T3odisvqT
@cactusncookies @ParisCole9 @Yamiche @NewsHour As a matter of fact, it has been proven to not work AT ALL in preventing someone from getting #COVID19. https://t.co/JssjzmTr70
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
#Health There was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19. https://t.co/7IOJrSGcTB
RT @FarmaMadridAP: (JAMA) Hidroxicloroquina en profilaxis pre-exposición entre los trabajadores de la salud de los hospitales: no previno l…
RT @josegallucci: 👉 HCQ com mais um RCT negativo publicado. Um recorde de RCTs negativos. Efficacy and Safety of Hydroxychloroquine vs Plac…
Efficacy & Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: RCT Among hospital-based health care workers, daily hydroxychloroquine did not prevent #COVID19 infection https://t.co/gpmkxHwOQa ht
RT @isabellesmullen: It was a real privilege to work on this rigorous, timely trial with the PATCH team and the healthcare workers who part…
@MSignorile @MollyJongFast Won't do any good, according to new study in JAMA. https://t.co/KNgoCLoDLp
RT @TimLaheyMD: Another negative HCQ trial, this time as pre-exposure prophylaxis in HCW https://t.co/JcJQZyN1hD
RT @JAMAInternalMed: #Hydroxychloroquine taken daily by hospital-based health care providers over 8 weeks did not prevent #SARSCoV2 infecti…
E por falar na dita cuja, cerca de 60 profissionais de saúde tomaram 600mg diárias de HCQ por 2 meses como tratamento preventivo da covid-19. (A outra metade ficou com placebo.) Ao contrário do que Jair costuma dizer, não funcionou. https://t.co/pNeO76fpzV
RT @ABsteward: NEW 🔥🔥@JAMAInternalMed Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among He…
RT @rigotordoc: Eficacia y seguridad de la #hidroxicloroquina frente al placebo para la #profilaxis del #SARSCoV2 antes de la exposición en…
RT @jameshamblin: Another clinical trial of hydroxychloroquine shows no benefit over placebo https://t.co/VsqZC40UqC
RT @MJR_5555: Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care... https://t.c…
RT @carpe_diem0820: COVID-19患者の診療にあたる医療従事者が暴露前予防としてヒドロキシクロロキンを8週間毎日服用しても、臨床的な有益性は認められなかった Efficacy and Safety of Hydroxychloroquine vs Pla…
Efficacy & Safety of HCQ vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among HCWs "there was no clinical benefit of [HCQ] administered daily for 8 weeks as pre-exposure prophylaxis in hospital-based HCWs exposed to patients with COVID-19." https
RT @KariTikkinen: One more randomized trial showing no efficacy of #Hydroxychloroquine for #COVID - this time for pre-exposure prophylaxis…
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @richardursomd: Here’s why this study is worthless! https://t.co/LyLdusnkbo
RT @OJBoyau: Et encore une étude. Donc HCQ ça fonctionne pas en prophylaxie, en précoce, en tardif, associé ou non à AZT. Et avec plus d'ef…
Finally a study of prophylaxis on health care workers. https://t.co/PJ0ICVO42N
RT @damiani_petri: Não há uma mísera evidência pra essa droga, nem antes, nem leve, nem grave... Mas o dia D com kit covid vai bombar... h…
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla? https://t.co/vpFi4pDEIS
RT @giordanopg: ¿Ya? ¿Ahora sí ya van a dejar de recetarla?
Não há uma mísera evidência pra essa droga, nem antes, nem leve, nem grave... Mas o dia D com kit covid vai bombar... https://t.co/nDy4jXbaCv
RT @omendiz: No sirvió para prevenir Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Hea…
RT @carpe_diem0820: COVID-19患者の診療にあたる医療従事者が暴露前予防としてヒドロキシクロロキンを8週間毎日服用しても、臨床的な有益性は認められなかった Efficacy and Safety of Hydroxychloroquine vs Pla…
COVID-19患者の診療にあたる医療従事者が暴露前予防としてヒドロキシクロロキンを8週間毎日服用しても、臨床的な有益性は認められなかった Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers https://t.co/XtD3C03Bpw https://t.co/HeOKvF5hVK
RT @gbiondizoccai: Anyone surprised that #hydroxychloroquine is not useful as a preventive strategy againts #Covid_19? I guess not... Anyho…
RT @CollignonPeter: In this randomized clinical there was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-e…
RT @CollignonPeter: In this randomized clinical there was no clinical benefit of hydroxychloroquine administered daily for 8 weeks as pre-e…
RT @CollignonPeter: 132 participants (median age, 33 years [range, 20-66 years]. There was no significant difference in infection rates in…